Objectives: This study sought to compare various measures of adiposity with risk for incident
hospitalized heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection …

Background and aims Cell adhesion molecules (CAMs) are implicated in the initiation and
progression of atherosclerosis, but their association with risk of type 2 diabetes remains …

Background Serum levels of vascular cell adhesion molecule‐1 (VCAM‐1) are reflective of
endothelial activation. Although VCAM‐1 has been implicated in the pathogenesis of heart …

Background E-selectin and intercellular adhesion molecule (ICAM)-1 are biomarkers of
endothelial activation, which has been implicated in the pathogenesis of heart failure (HF) …

Background The therapeutic management of obesity is challenging, hence further
elucidating the underlying mechanisms of obesity development and identifying new …

Context: Obesity is associated with poor bone mineralization and quality. Fibroblast growth
factor 23 (FGF23) plays an important role in skeletal physiology. Objective: To test …

Background The impact of obesity and dyslipidemia on cardiovascular health in adolescents
and young adults with diabetes is incompletely understood. This study evaluated the effects …

Objective We investigated whether the associations of serum adiponectin, leptin, and
resistin with adiposity differ with menopausal age. Methods In this cross-sectional study, we …

Purpose As life expectancy in cystic fibrosis (CF) increases, questions regarding its potential
impact on cardiovascular health arise. Soluble vascular cell adhesion molecule 1 (sVCAM …

Circulating protease inhibitors are important regulators of inflammation that are implicated in
the pathophysiology of heart failure (HF). Secretory leukocyte protease inhibitor (SLPI) is a …